Lilly’s Oral GLP-1 Orforglipron Meets Phase 3 Endpoints in Obesity and Diabetes, Regulatory Filings Planned Read more about Lilly’s Oral GLP-1 Orforglipron Meets Phase 3 Endpoints in Obesity and Diabetes, Regulatory Filings Planned
UI Health Performs First FDA-Approved Islet Cell Transplant with Lantidra Read more about UI Health Performs First FDA-Approved Islet Cell Transplant with Lantidra
Semaglutide Not Linked to Higher Risk of Diabetic Retinopathy or Eye Disorders, Meta-analysis Finds Read more about Semaglutide Not Linked to Higher Risk of Diabetic Retinopathy or Eye Disorders, Meta-analysis Finds
Engineered Peptide Shows Promise for Diabetic Wound Infection Repair Read more about Engineered Peptide Shows Promise for Diabetic Wound Infection Repair
Metformin Alters Blood Metal Levels, Shedding Light on Its Broad Benefits Read more about Metformin Alters Blood Metal Levels, Shedding Light on Its Broad Benefits
T1D Patients With ASCVD Gain Significant Benefit From Evolocumab Tags Coronary artery disease Read more about T1D Patients With ASCVD Gain Significant Benefit From Evolocumab
Walking Made Easier: Semaglutide Shows Promise for PAD and Diabetes Tags Peripheral vascular disease Read more about Walking Made Easier: Semaglutide Shows Promise for PAD and Diabetes
Are Thiazolidinediones Effective in Reducing the Risk of Renal Complications and Death in Patients with Diabetes? Tags Diabetic Nephropathy Read more about Are Thiazolidinediones Effective in Reducing the Risk of Renal Complications and Death in Patients with Diabetes?
Canagliflozin Effective in Treating Type 2 Diabetes in Children and Adolescents Read more about Canagliflozin Effective in Treating Type 2 Diabetes in Children and Adolescents
Faricimab Shows Promising 12-Month Outcomes in Diabetic Macular Edema Patients Unresponsive to Aflibercept Tags Retinopathy Retinopathy Read more about Faricimab Shows Promising 12-Month Outcomes in Diabetic Macular Edema Patients Unresponsive to Aflibercept